UChicago Medicine Faculty Physicians
Hedy Lee Kindler, MD
Hedy Lee Kindler, MD
UChicago Medicine Faculty Physicians
Professor of Medicine
Director, Multidisciplinary Mesothelioma Program
Specialties
- Hematology and Oncology (Cancer)
Locations
- Chicago - Hyde Park
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Hedy Lee Kindler, MD, is an internationally recognized cancer expert who specializes in the medical treatment of pancreatic cancer, gastrointestinal stromal tumors and malignant mesothelioma (a type of lung cancer caused by asbestos exposure). Her research focuses on the investigation of novel agents for the treatment of these cancers, and she designs and leads many innovative clinical trials for patients with these diseases.
Dr. Kindler is an associate editor of Lung Cancer and has published numerous journal articles, review articles, book chapters, and abstracts. A popular speaker, she has been invited to lecture at hundreds of scientific meetings around the world.
Dr. Kindler is the immediate past-president of the International Mesothelioma Interest Group. She is an active member of several committees and boards, including the Science Advisory Board of the Mesothelioma Foundation, the NCI Pancreatic Cancer Task Force and the Alliance for Clinical Trials in Oncology.
Repeatedly listed in Best Doctors in America, America’s Top Doctors for Cancer, and Top Doctors in Chicago. Dr. Kindler was recently awarded the Selikoff Lifetime Achievement Award by the Asbestos Disease Awareness Organization.
Dr. Kindler is an associate editor of Lung Cancer and has published numerous journal articles, review articles, book chapters, and abstracts. A popular speaker, she has been invited to lecture at hundreds of scientific meetings around the world.
Dr. Kindler is the immediate past-president of the International Mesothelioma Interest Group. She is an active member of several committees and boards, including the Science Advisory Board of the Mesothelioma Foundation, the NCI Pancreatic Cancer Task Force and the Alliance for Clinical Trials in Oncology.
Repeatedly listed in Best Doctors in America, America’s Top Doctors for Cancer, and Top Doctors in Chicago. Dr. Kindler was recently awarded the Selikoff Lifetime Achievement Award by the Asbestos Disease Awareness Organization.
Specialties
Areas of Expertise
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Medical Oncology
Practicing Since
- 1995
Languages Spoken
- English
Medical Education
- State University of New York College of Medicine
Residency
- University of California Los Angeles Health; Montefiore Medical Center
Fellowship
- Memorial Sloan Kettering Cancer Center
Memberships & Medical Societies
- American Association for Cancer Research
- International Association for the Study of Lung Cancer
- Mesothelioma Applied Research Foundation
- Alliance for Clinical Trials in Oncology
- American Society of Clinical Oncology
- International Mesothelioma Interest Group
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.